Assignee
HEPAREGENIX GMBH
DE·6 granted patents·2 pending applications·9 citations·filing 2018–2023
Top patents by PatentIndex Score
8 records- 0179US11040027B2Protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte deathHEPAREGENIX GMBH·Filed 2018·Granted Jun 22, 2021·5 cites·15 claims
- 0277US11912701B2Protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte deathHEPAREGENIX GMBH·Filed 2019·Granted Feb 27, 2024·2 cites·18 claims
- 0372US11858927B2Protein kinase MKK4 inhibitors for promoting liver regeneration or reducing or preventing hepatocyte deathHEPAREGENIX GMBH·Filed 2019·Granted Jan 2, 2024·1 cites·19 claims
- 0470US11731968B2Tricyclic protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte deathHEPAREGENIX GMBH·Filed 2019·Granted Aug 22, 2023·1 cites·11 claims
- 0567US12264158B2Protein kinase MKK4 inhibitors for promoting liver regeneration or reducing or preventing hepatocyte deathHEPAREGENIX GMBH·Filed 2023·Granted Apr 1, 2025·0 cites·7 claims
- 0663US2025228834A1Pharmaceutical composition for the treatment of colon and lung cancerHEPAREGENIX GMBH·Filed 2023·Application pending·0 cites
- 0758US12466826B23-benzoyl-1H-pyrrolo[2,3-b]pyridine derivatives as MKK4 inhibitors for treating liver diseasesHEPAREGENIX GMBH·Filed 2021·Granted Nov 11, 2025·0 cites·13 claims
- 0849US2022340561A1Heteroaryl-substituted pyrazolo-pyridine protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte deathHEPAREGENIX GMBH·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →